Skip to main content
SpringerLink
Log in

Insulin resistance, microalbuminuria, and chronic kidney disease

  • Invited Commentary
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sarafidis PA, Nilsson PM: The metabolic syndrome: a glance at its history. J Hypertens 2006, 24:621–626.

    Article  PubMed  CAS  Google Scholar 

  2. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595–1607.

    Article  PubMed  CAS  Google Scholar 

  3. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289–2304.

    Article  PubMed  Google Scholar 

  4. Sarafidis PA: Metabolic syndrome and arterial stiffness: evidence for gender disparity and early effects of non-traditional risk factors? J Hypertens 2007, 25:935–938.

    Article  PubMed  CAS  Google Scholar 

  5. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease: Am J Kidney Dis 2004, 43:1–290.

  6. American Diabetes Association: Nephropathy in diabetes. Diabetes Care 2004, 27(Suppl 1):S79–S83.

    Google Scholar 

  7. Khosla N, Sarafidis PA, Bakris GL: Microalbuminuria. Clin Lab Med 2006, 26:635–653.

    Article  PubMed  Google Scholar 

  8. Sarafidis PA, Bakris GL: Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant 2006, 21:2366–2374.

    Article  PubMed  Google Scholar 

  9. Viberti GC, Hill RD, Jarrett RJ, et al.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1:1430–1432.

    Article  PubMed  CAS  Google Scholar 

  10. Niskanen L, Laakso M: Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 1993, 42:1541–1545.

    Article  PubMed  CAS  Google Scholar 

  11. Forsblom CM, Eriksson JG, Ekstrand AV, et al.: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995, 38:363–369.

    Article  PubMed  CAS  Google Scholar 

  12. Bianchi S, Bigazzi R, Nenci R, Campese VM: Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension. J Nephrol 1997, 10:325–333.

    PubMed  CAS  Google Scholar 

  13. Mykkanen L, Zaccaro DJ, Wagenknecht LE, et al.: Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998, 47:793–800.

    Article  PubMed  CAS  Google Scholar 

  14. De Cosmo S, Minenna A, Ludovico O, et al.: Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. Diabetes Care 2005, 28:910–915.

    Article  PubMed  Google Scholar 

  15. Kim CH, Kim HK, Park JY, et al.: Association of microal-buminuria and atherosclerotic risk factors in non-diabetic subjects in Korea. Diabetes Res Clin Pract 1998, 40:191–199.

    Article  PubMed  CAS  Google Scholar 

  16. Kim YI, Kim CH, Choi CS, et al.: Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract 2001, 52:145–152.

    Article  PubMed  CAS  Google Scholar 

  17. Wirta OR, Pasternack AI, Mustonen JT, et al.: Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant 1996, 11:449–456.

    PubMed  CAS  Google Scholar 

  18. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286–1292.

    Article  PubMed  CAS  Google Scholar 

  19. Abuaisha B, Kumar S, Malik R, Boulton AJ: Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998, 39:93–99.

    Article  PubMed  CAS  Google Scholar 

  20. Spangler JG, Konen JC: Hypertension, hyperlipidemia, and abdominal obesity and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus. J Am Board Fam Pract 1996, 9:1–6.

    PubMed  CAS  Google Scholar 

  21. Rowley KG, Iser DM, Best JD, et al.: Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia 2000, 43:1397–1403.

    Article  PubMed  CAS  Google Scholar 

  22. Hoehner CM, Greenlund KJ, Rith-Najarian S, et al.: Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 2002, 13:1626–1634.

    Article  PubMed  CAS  Google Scholar 

  23. Chen J, Muntner P, Hamm LL, et al.: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004, 140:167–174.

    PubMed  Google Scholar 

  24. Hodge AM, Dowse GK, Zimmet PZ: Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996, 13:441–449.

    Article  PubMed  CAS  Google Scholar 

  25. Jager A, Kostense PJ, Nijpels G, et al.: Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 1998, 41:694–700.

    Article  PubMed  CAS  Google Scholar 

  26. Srinivasan SR, Myers L, Berenson GS: Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study. Am J Hypertens 2000, 13:1274–1279.

    Article  PubMed  CAS  Google Scholar 

  27. World Health Organization: Definition Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification Of Diabetes Mellitus. Geneva: World Health Organization; 1999.

    Google Scholar 

  28. Emoto M, Nishizawa Y, Maekawa K, et al.: Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy. Metabolism 1997, 46:1013–1018.

    Article  PubMed  CAS  Google Scholar 

  29. Kobayashi S, Maesato K, Moriya H, et al.: Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005, 45:275–280.

    Article  PubMed  CAS  Google Scholar 

  30. Chen J, Muntner P, Hamm LL, et al.: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003, 14:469–477.

    Article  PubMed  CAS  Google Scholar 

  31. Muntner P, He J, Chen J, et al.: Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 2004, 14:686–695.

    Article  PubMed  Google Scholar 

  32. Thorn LM, Forsblom C, Fagerudd J, et al.: Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005, 28:2019–2024.

    Article  PubMed  Google Scholar 

  33. Segura J, Campo C, Roldan C, et al.: Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances. J Am Soc Nephrol 2004, 15Suppl 1:S37–S42.

    Article  PubMed  Google Scholar 

  34. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005, 16:2134–2140.

    Article  PubMed  Google Scholar 

  35. Fox CS, Larson MG, Leip EP, et al.: Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 2005, 28:2436–2440.

    Article  PubMed  Google Scholar 

  36. Stenvinkel P, Bolinder J, Alvestrand A: Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia 1992, 35:1042–1048.

    Article  PubMed  CAS  Google Scholar 

  37. Sarafidis PA, Bakris GL: Protection of the kidney by thiazolidinediones: an assessment from bench to bedside. Kidney Int 2006, 70:1223–1233.

    Article  PubMed  CAS  Google Scholar 

  38. Sarafidis PA: Thiazolidinediones and diabetic nephropathy: need for a closer examination? J Cardiometab Syndr 2007, 2:297–301.

    Article  PubMed  Google Scholar 

  39. Sarafidis PA, Ruilope LM: Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006, 26:232–244.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Nephrology and Hypertension, First Department of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636, Thessaloniki, Greece

    Pantelis A. Sarafidis

Authors
  1. Pantelis A. Sarafidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pantelis A. Sarafidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarafidis, P.A., Ruilope, L.M. Insulin resistance, microalbuminuria, and chronic kidney disease. Current Science Inc 10, 249–251 (2008). https://doi.org/10.1007/s11906-008-0046-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-008-0046-6

Keywords

Search

Navigation